Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001178913-24-003001
Filing Date
2024-09-09
Accepted
2024-09-09 06:16:11
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 zk2432003.htm 424B3 346842
2 image0.jpg GRAPHIC 186014
3 image1.jpg GRAPHIC 191023
  Complete submission text file 0001178913-24-003001.txt   867396
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-281750 | Film No.: 241285738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)